The COVID-19 pandemic's impact on worry and medical disruptions reported by individuals with chromosome 22q11.2 copy number variants and their caregivers.

Journal: Journal of intellectual disability research : JIDR

Volume: 66

Issue: 4

Year of Publication: 2022

Affiliated Institutions:  Lifespan Brain Institute, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Geisinger Autism & Developmental Medicine Institute, Geisinger Health System, Lewisburg, PA, USA. Instituto de Genética Médica y Molecular, Hospital Universitario La Paz, Madrid, Spain. Center for Genetics and Genomics, Facultad de Medicina Clínica Alemana - Universidad del Desarrollo, Santiago, Chile. Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK. Clinic and Policlinic for Psychiatry and Psychotherapy, University of Rostock, Rostock, Germany. Sainte Justine Research Center, University of Montreal, Montreal, Canada. Service des Troubles du Spectre de l'Autisme (STSA), Lausanne University Hospital, Lausanne, Switzerland. Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa. Centre for Addiction and Mental Health, University Health Network and Department of Psychiatry, University of Toronto, Toronto, Canada. Center for Human Genetics, University Hospital Leuven and Department of Human Genetics, KU Leuven, Leuven, Belgium.

Abstract summary 

The world has suffered immeasurably during the COVID-19 pandemic. Increased distress and mental and medical health concerns are collateral consequences to the disease itself. The Genes to Mental Health (G2MH) Network consortium sought to understand how individuals affected by the rare copy number variations of 22q11.2 deletion and duplication syndrome, associated with neurodevelopmental/neuropsychiatric conditions, were coping. The article focuses on worry and disruptions in medical care caused by the pandemic.The University of Pennsylvania COVID-19 Stressor List and care disruption questions were circulated by 22 advocacy groups in English and 11 other languages.A total of 512 people from 23 countries completed the survey; most were caregivers of affected individuals. Worry about family members acquiring COVID-19 had the highest average endorsed worry, whilst currently having COVID-19 had the lowest rated worry. Total COVID-19 worries were higher in individuals completing the survey towards the end of the study (later pandemic wave); 36% (n = 186) of the sample reported a significant effect on health due to care interruption during the pandemic; 44% of individuals (n = 111) receiving care for their genetic syndrome in a hospital setting reported delaying appointments due to COVID-19 fears; 12% (n = 59) of the sample reported disruptions to treatments; and of those reporting no current disruptions, 59% (n = 269) worried about future disruptions if the pandemic continued. Higher levels of care disruptions were related to higher COVID-19 worries (Ps < 0.005). Minimal differences by respondent type or copy number variation type emerged.Widespread medical care disruptions and pandemic-related worries were reported by individuals with 22q11.2 syndrome and their family members. Reported worries were broadly consistent with research results from prior reports in the general population. The long-term effects of COVID-19 worries, interruptions to care and hospital avoidance require further study.

Authors & Co-authors:  White L K LK Crowley T B TB Finucane B B Garcia-Minaur S S Repetto G M GM van den Bree M M Fischer M M Jacquemont S S Barzilay R R Maillard A M AM Donald K A KA Gur R E RE Bassett A S AS Swillen A A McDonald-McGinn D M DM

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Barzilay R, Moore TM, Greenberg DM, DiDomenico GE, Brown LA, White LK, Gur RC, et al. (2020), “Resilience, COVID-19-related stress, anxiety and depression during the pandemic in a large population enriched for healthcare providers”, Translational Psychiatry, Vol. 10 No. 1, p. 291.
Authors :  15
Identifiers
Doi : 10.1111/jir.12918
SSN : 1365-2788
Study Population
Male,Female
Mesh Terms
COVID-19
Other Terms
22q11.2 deletion syndrome;22q11.2 duplication syndrome;COVID-19;copy number variations (CNVs);neurodevelopmental psychiatric disorders (NPDs)
Study Design
Cross Sectional Study
Study Approach
Country of Study
Publication Country
England